Adene Sanchez | E+ | Getty Images Company: Exelixis (EXEL) Business: Exelixis, an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. They have produced four marketed pharmaceutical products, including their flagship molecule, cabozantinib. Stock Market Value: $6.3B ($19.46 per share) Activist: Farallon Capital
0 Comments
Large, blue-chip dividend stocks are popular with investors due to their sleep-well-at-night qualities and ability to offer attractive, risk-adjusted, long-term wealth and income compounding. However, small-cap stocks have the potential to yield superior total returns. This is due to their higher growth potential and tendency to offer higher dividend yields. Indeed, small-cap stocks may involve
0 Comments
If your portfolio doesn’t have some exposure to artificial intelligence (AI), you’re a little late to the party. That’s okay, though, as it’s not too late to take a position in Microsoft (NASDAQ:MSFT) stock. No doubt about it — Microsoft will continue to push the boundaries in the generative AI field this year, and thereby deliver outstanding
0 Comments
Are all regional American banks the same? Definitely not! U.S. Bancorp (NYSE:USB) stands apart from failed banks for being consistently profitable while respecting shareholders with generous dividend payouts. At the end of the day, you’ll surely find that USB stock didn’t deserve its recent sharp drawdown and is poised for a swift comeback. It’s understandable that
0 Comments
Have you ever thought about investing in a Swiss bank? It’s actually not a bad idea, especially if we’re talking about UBS Group (NYSE:UBS). First of all, UBS stock is trading at a reasonable valuation. Plus, UBS Group’s takeover of Credit Suisse (NYSE:CS) shouldn’t be as troublesome as some fearmongers would have you believe. Banking-sector contagion isn’t
0 Comments
In this article JPM MOMO LCID BLK Follow your favorite stocksCREATE FREE ACCOUNT Getty Images Check out the companies making headlines in premarket trading. JPMorgan Chase – The banking behemoth popped more than 5% after posting record revenue that surpassed analyst expectations due to higher interest rates. JPMorgan Chase reported revenue of $39.34 billion, beating
0 Comments
Dividend stocks remain at the top of investors’ radar. Not only do these companies pay out a portion of their cash flow to shareholders, but many do so consistently. This consistency has attracted investors over the years, particularly buy-and-hold investors. With the rise in Treasury yields over the last year, dividend stocks have faced more
0 Comments
Among cannabis stocks, SNDL (NASDAQ:SNDL) has been one that screens well as a value play. Even though this Canada-based integrated cannabis company isn’t cheap on a price-to-earnings basis, SNDL stock has for quite some time traded at a discount to its tangible book value. But investors who have bought it based on its low valuation
0 Comments
Artificial intelligence (AI) is a powerful technology that will enable many businesses to both save money and accelerate growth. As a result, demand for powerful, efficient AI tools is likely to explode, and companies that can deliver them will be quite prosperous. Today, we’ll look at three of the best AI stocks on the market.
0 Comments
Is it possible for a retail apparel outlet to thrive when the economy is shaky? Yes, it is definitely possible as Burlington Stores (NYSE:BURL) caters to discount hunters, an advantage during elevated inflation. Sure, it’s somewhat risky to invest in retail apparel stocks, but Burlington’s favorable current-quarter outlook indicates BURL stock could run higher. Headquartered
0 Comments
While trading with the masses may generally be the wisest approach, contrarian gamblers may accrue dramatic profitability through short-squeeze stocks. To get everyone on the same page, coordinated investments in heavily shorted securities can potentially trigger ridiculous upside as bears panic out of their positions. This panicking results in bears buying the affected securities (since
0 Comments